DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $891,919 | -1.5% | 3,595 | -4.7% | 0.54% | +4.4% |
| Q2 2023 | $905,760 | -9.9% | 3,774 | -5.4% | 0.52% | -16.9% |
| Q1 2023 | $1,005,388 | -6.5% | 3,989 | -1.5% | 0.63% | -11.4% |
| Q4 2022 | $1,074,951 | +4.5% | 4,050 | +1.7% | 0.71% | -1.5% |
| Q3 2022 | $1,029,000 | +0.6% | 3,983 | -1.3% | 0.72% | +5.3% |
| Q2 2022 | $1,023,000 | -12.9% | 4,034 | +0.8% | 0.68% | +7.2% |
| Q1 2022 | $1,174,000 | -17.1% | 4,003 | -7.0% | 0.64% | -8.9% |
| Q4 2021 | $1,416,000 | +8.8% | 4,305 | +0.7% | 0.70% | +3.9% |
| Q3 2021 | $1,301,000 | +13.5% | 4,275 | +0.1% | 0.67% | +16.6% |
| Q2 2021 | $1,146,000 | +23.2% | 4,271 | +3.4% | 0.58% | +17.5% |
| Q1 2021 | $930,000 | +5.3% | 4,130 | +3.8% | 0.49% | -4.8% |
| Q4 2020 | $883,000 | +7.2% | 3,977 | +3.9% | 0.52% | -12.2% |
| Q3 2020 | $824,000 | +24.3% | 3,827 | +2.1% | 0.59% | +14.1% |
| Q2 2020 | $663,000 | +35.6% | 3,749 | +6.2% | 0.52% | +5.5% |
| Q1 2020 | $489,000 | -5.0% | 3,530 | +5.1% | 0.49% | +37.4% |
| Q4 2019 | $515,000 | +8.4% | 3,358 | +2.1% | 0.36% | 0.0% |
| Q3 2019 | $475,000 | +1.1% | 3,289 | -0.1% | 0.36% | -3.0% |
| Q2 2019 | $470,000 | -26.3% | 3,292 | -31.9% | 0.37% | -29.2% |
| Q1 2019 | $638,000 | +31.5% | 4,833 | +2.8% | 0.52% | +15.4% |
| Q4 2018 | $485,000 | -7.6% | 4,700 | -2.8% | 0.45% | +22.3% |
| Q3 2018 | $525,000 | +13.4% | 4,836 | +3.2% | 0.37% | +11.9% |
| Q2 2018 | $463,000 | +1.8% | 4,688 | +0.9% | 0.33% | -1.2% |
| Q1 2018 | $455,000 | +25.3% | 4,646 | +18.7% | 0.33% | +27.7% |
| Q4 2017 | $363,000 | +9.3% | 3,915 | +1.2% | 0.26% | +11.6% |
| Q3 2017 | $332,000 | +5.7% | 3,870 | +3.9% | 0.23% | +2.6% |
| Q2 2017 | $314,000 | +1.3% | 3,725 | +2.8% | 0.23% | -2.2% |
| Q1 2017 | $310,000 | +19.2% | 3,625 | +8.5% | 0.23% | +22.1% |
| Q4 2016 | $260,000 | – | 3,340 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |